What Is Semaglutide? A Guide to Ozempic, Wegovy, and Rybelsus

Semaglutide is a GLP-1 receptor agonist (a type of diabetes and weight management medication) manufactured by Novo Nordisk. It is the active ingredient in three brand-name drugs: Ozempic, Wegovy, and Rybelsus. All three contain semaglutide but are approved for different conditions and come in different forms.

If you have been wondering whether semaglutide is the same as Ozempic, the short answer is yes and no. Semaglutide is the generic ingredient. Ozempic is one of its brand names. Understanding this distinction can save you from confusion when reading prescriptions, pharmacy labels, or health articles.

This guide, based on FDA prescribing information and published clinical trial data, covers everything you need to know about semaglutide: how it works, what each brand treats, injection versus tablet forms, common side effects, and availability in the UAE. MedX Pharmacy stocks the Ozempic (semaglutide) pen in injectable form. All prescription medications require a valid prescription from a licensed healthcare provider.

How Semaglutide Works in Your Body

Semaglutide mimics a natural hormone called GLP-1 (glucagon-like peptide-1) that your body releases after eating. It signals the pancreas to produce more insulin, tells the liver to reduce glucose output, slows stomach emptying so you feel full longer, and acts on appetite centres in the brain to reduce hunger. These combined effects lower blood sugar levels and can lead to weight loss.

In simpler terms, semaglutide works like a volume dial for your appetite and blood sugar. After a meal, your body naturally produces GLP-1 to manage digestion. Semaglutide is a longer-lasting version of that same signal. It stays active in the body for about a week, which is why the injectable forms are dosed once weekly. You can read more in the StatPearls semaglutide reference.

Because semaglutide affects multiple systems at once, it has shown benefits beyond blood sugar control. Clinical trials have documented improvements in cardiovascular risk markers, kidney function, and body weight. Your healthcare provider can help determine whether these benefits are relevant to your situation.

Semaglutide Brand Names: Ozempic, Wegovy, Rybelsus

Ozempic is FDA-approved for type 2 diabetes, cardiovascular risk reduction, and chronic kidney disease. Wegovy is approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition, and for cardiovascular risk reduction. Rybelsus is approved for type 2 diabetes as a daily oral tablet. All three contain semaglutide at different doses and in different forms.

In February 2026, the FDA approved rebranding the oral semaglutide tablet (previously Rybelsus) under the Ozempic name. This means Ozempic is now available as both a once-weekly injection and a daily pill. The decision was driven by the higher brand recognition of Ozempic compared to Rybelsus. You can learn more at the official Ozempic website.

The select trial showed that Wegovy reduced major cardiovascular events by 20%. The newer Wegovy HD 7.2mg injection, launched in April 2026, provides a higher dose option for eligible patients. It is important to note that these brands are not interchangeable. Each has different approved uses, doses, and forms. Switching between them requires guidance from your healthcare provider.

MedX Pharmacy carries the Ozempic 0.5mg semaglutide pen alongside other dosage strengths. All prescription medications require a valid prescription from a licensed healthcare provider.

Semaglutide Injection vs Tablet

The injectable form of semaglutide (Ozempic, Wegovy) is administered once per week using a pre-filled pen. You inject it under the skin of your abdomen, thigh, or upper arm. The weekly schedule means fewer doses to remember compared to daily medications.

The oral tablet form requires a specific routine. You must take it on an empty stomach with no more than 120ml (about 4 ounces) of plain water. Then wait at least 30 minutes before eating, drinking anything else, or taking other medications. Food and liquids reduce the tablet's absorption, so following this routine is essential for effectiveness.

With the February 2026 rebrand, the Ozempic pill is now available in 1.5mg, 4mg, and 9mg strengths. The original Rybelsus tablets (3mg, 7mg, 14mg) remain available during the transition period. Your doctor can advise which form and dose suits your condition. MedX Pharmacy currently stocks the Ozempic 1mg semaglutide pen in injectable form. MedX does not carry oral semaglutide tablets at this time. All prescription medications require a valid prescription from a licensed healthcare provider.

Common Side Effects of Semaglutide

Gastrointestinal side effects are the most frequently reported across all semaglutide brands. According to the FDA prescribing information for Ozempic, the most common side effects occurring in more than 5% of patients include nausea (15-20%), diarrhoea (8-9%), vomiting (5-9%), and constipation (5-6%). These effects are most common during the first few weeks and during dose increases.

Semaglutide carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Serious but less common side effects include pancreatitis, gallbladder problems, kidney injury, and diabetic retinopathy complications. If you experience severe abdominal pain, vision changes, or signs of an allergic reaction, contact your healthcare provider immediately. For additional side effect details, see the semaglutide drug information resource.

Semaglutide and Weight Loss

Wegovy is the only semaglutide brand FDA-approved specifically for chronic weight management. In the STEP clinical trials, participants using Wegovy lost an average of 12-15% of their body weight over 68 weeks. Wegovy is prescribed for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition.

Ozempic is not FDA-approved for weight loss. However, weight reduction is a commonly observed effect during diabetes treatment. In clinical trials, more than 86% of Ozempic patients lost at least 5% of their body weight. When healthcare providers prescribe Ozempic for weight management purposes, this is considered off-label use. You can read more about this topic in our guide on Ozempic for weight loss.

Regardless of which semaglutide brand is used, weight management with this medication requires ongoing medical supervision. Stopping the medication often leads to weight regain, so a long-term plan with your healthcare provider is essential.

Semaglutide vs Tirzepatide

Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight management). Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual GIP/GLP-1 receptor agonist. This dual action has shown greater weight loss results in the SURMOUNT clinical trials compared to semaglutide.

Both medications are injectable, administered once weekly, and share similar gastrointestinal side effects. The choice between them depends on your specific diagnosis, treatment goals, and your healthcare provider's recommendation. For a detailed side-by-side breakdown, see our article on GLP-1 medications compared.

Semaglutide in the UAE

In the UAE, semaglutide is available as a prescription medication. You will need a valid prescription from a licensed healthcare provider to purchase it. The most widely available semaglutide product is Ozempic in its injectable pen form.

MedX Pharmacy stocks Ozempic pre-filled pens in three dosage strengths: 0.25mg, 0.5mg, and 1mg. Market prices for Ozempic pens in the UAE typically range from AED 740 to AED 1,200 per pen, depending on dosage and supplier. MedX does not currently carry Wegovy, Rybelsus, or the new Ozempic oral tablet.

Frequently Asked Questions About Semaglutide

Is semaglutide the same as Ozempic?

Semaglutide is the active pharmaceutical ingredient. Ozempic is one of its brand names. Wegovy and Rybelsus also contain semaglutide. They all use the same drug molecule but are approved for different medical conditions and come in different doses. Think of semaglutide as the ingredient and Ozempic as the product name on the label.

What exactly does semaglutide do to your body?

Semaglutide mimics the GLP-1 hormone your body produces naturally after eating. It stimulates insulin production, slows stomach emptying, and reduces appetite signals in the brain. The combined result is lower blood sugar levels and, in many patients, reduced body weight. Effects build gradually over the first several weeks of treatment.

Is there a pill form of semaglutide?

Yes. Rybelsus was the original oral semaglutide tablet, available in 3mg, 7mg, and 14mg strengths. In February 2026, the FDA approved rebranding it as the Ozempic pill in 1.5mg, 4mg, and 9mg doses. The oral form must be taken on an empty stomach with a small amount of plain water, followed by a 30-minute wait before eating or drinking anything else.

What is the difference between Ozempic and Wegovy?

Both are semaglutide injections made by Novo Nordisk, but they target different conditions. Ozempic is FDA-approved for type 2 diabetes at doses up to 2mg per week. Wegovy is approved for chronic weight management at doses up to 2.4mg per week (injection) or 25mg per day (oral). They have different titration schedules and should not be used interchangeably without medical guidance.

Is semaglutide safe for weight loss?

Wegovy is FDA-approved for weight management and has demonstrated 12-15% average body weight loss over 68 weeks in clinical trials. Ozempic is not approved for weight loss, though it is sometimes prescribed off-label for this purpose. Gastrointestinal side effects are common with both. Any use of semaglutide for weight management should be supervised by a healthcare provider.

What happens if a non-diabetic takes semaglutide?

Semaglutide still affects appetite regulation and blood sugar even in people without diabetes. The risk of dangerously low blood sugar (hypoglycaemia) is low when semaglutide is used alone. However, gastrointestinal side effects such as nausea and diarrhoea still occur. Non-diabetic use of semaglutide requires a prescription and medical supervision, just like diabetic use.

Semaglutide Options Available at MedX Pharmacy

If your healthcare provider has prescribed semaglutide, you can browse Ozempic (semaglutide) products at MedX Pharmacy. MedX carries Ozempic injectable pens in 0.25mg, 0.5mg, and 1mg strengths. A healthcare provider can help determine whether Ozempic is appropriate for your condition. All prescription medications require a valid prescription from a licensed healthcare provider.

Key Takeaways

Semaglutide is the active ingredient behind three major brand-name medications: Ozempic for type 2 diabetes, Wegovy for weight management, and Rybelsus (now rebranded as the Ozempic pill) for type 2 diabetes in oral form. Each brand serves a different purpose, uses different doses, and is not interchangeable without medical guidance.

Understanding the brand-versus-generic landscape helps you have more informed conversations with your healthcare provider. If you are exploring semaglutide options, start with our complete Ozempic guide or browse our full selection of diabetes and weight management medications.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. The information presented is based on publicly available clinical data and prescribing information current at the time of writing. MedX Pharmacy is a licensed pharmacy; all prescription medications require a valid prescription from a licensed healthcare provider.